参考文献/References:
[1]Huang H,Chen B,Liu G,et al.A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii[J].BMC Infectious Diseases,2018,18(1):11.[2]唐晓莹,浦雄勇.T淋巴细胞亚群及其细胞因子测定对鲍曼不动杆菌感染与定植的鉴别诊断效果[J].检验医学与临床,2019,16(22):3280-3283,3288. [3]Kim B,Kim K,Yoon JS.Nosocomial Acinetobacter baumannii infection in children in adult versus pediatric intensive care units[J].Pediatr Int,2020,62(4):451-458.[4]宋骏,黄升海,钟民.鉴别鲍曼不动杆菌定植与感染的临床指标研究[J].安徽医科大学学报,2018,53(6):967-970. [5]Aboshakwa AM,Lalla U,Irusen E,et al.Acinetobacter baumannii infection in a medical intensive care unit: The impact of strict infection control[J].African Journal of Thoracic and Critical Care Medicine,2019,25(1):10.[6]Yamamoto N,Hamaguchi S,Akeda Y,et al.Rapid screening and early precautions for carbapenem-resistant Acinetobacter baumannii carriers decreased nosocomial transmission in hospital settings: a quasi-experimental study[J].Antimicrob Resist Infect Control,2019(8):110.[7]袁瑞丽,杨云娇,李菁.抗中性粒细胞胞浆抗体相关性血管炎感染患者淋巴细胞及CD4+T细胞减少与死亡的相关性[J].中华临床免疫和变态反应杂志,2020,14(2):124-129. [8]庞雅,陈雄发.PCT、NLR、hs-CRP在鲍曼不动杆菌定植和感染的鉴别运用[J].中国处方药,2020,18(11):149-150.[9]Papadimitriou-Olivgeris M,Fligou F,Spiliopoulou A,et al.Risk factors and predictors of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii mortality in critically ill bacteraemic patients over a 6-year period (2010-15): antibiotics do matter[J].J Med Microbiol,2017,66(8):1092-1101.[10]韩忠学,刘静,巩静.降钙素原在鲍曼不动杆菌定植与感染鉴别中的应用[J].国际检验医学杂志,2017,38(3):407-408. [11]许娜娜,王昊,周敏.机械通气患者泛耐药鲍曼不动杆菌定植与感染的危险因素分析[J].中国消毒学杂志,2019,36(6):439-442.[12]高鸿章.EICU和ICU患者鲍曼不动杆菌定植、感染发生率及治疗和转归情况调查研究[J].中国现代药物应用,2018,12(7):74-75.[13]温婵,耿蓉娜,赵博,等.2011-2014年某儿童医院多药耐药鲍曼不动杆菌临床分布及感染/定植情况分析[J].现代预防医学,2016,43(5):936-938,960.[14]隋文君,王玫,黄艳飞,等.多重耐药鲍曼不动杆菌定植与感染表达差异的分析[J].中华医学杂志,2016,96(41):3319-3323. [15]谭建龙,刘志光,邓红英,等.支气管肺泡灌洗液可溶性髓样细胞触发受体-1在下呼吸道鲍曼不动杆菌感染与定植中的鉴别诊断价值[J].中国呼吸与危重监护杂志,2020,19(5):446-450. [16]刘基铎,郭心怡,肖明锋,等.探讨在细菌性感染及病毒性感染疾病中淋巴细胞亚群的表达水平及意义[J].中华临床实验室管理电子杂志,2020,8(4):65-69.[17]Lee CR,Lee JH,Park M,et al.Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options[J].Front Cell Infect Microbiol,2017(7):55.
相似文献/References:
[1]李淑惠.鲍曼不动杆菌临床分布及耐药性分析[J].医学信息,2018,31(03):165.[doi:10.3969/j.issn.1006-1959.2018.03.061]
LI Shu-hui.Clinical Distribution and Drug Resistance of Acinetobacter Baumannii[J].Medical Information,2018,31(20):165.[doi:10.3969/j.issn.1006-1959.2018.03.061]
[2]李佳颖,李春霖,王玉莹,等.鲍曼不动杆菌的单药治疗及其联合使用的研究[J].医学信息,2019,32(05):48.[doi:10.3969/j.issn.1006-1959.2019.05.016]
LI Jia-ying,LI Chun-lin,WANG Yu-ying,et al.Monotherapy of Acinetobacter Baumannii and Its Combined Use[J].Medical Information,2019,32(20):48.[doi:10.3969/j.issn.1006-1959.2019.05.016]
[3]常 琪,魏韵佳,穆 琪,等.2016~2018年鲍曼不动杆菌临床分离株的
分布特征及耐药性变迁[J].医学信息,2019,32(16):119.[doi:10.3969/j.issn.1006-1959.2019.16.038]
CHANG Qi,WEI Yun-jia,MU Qi,et al.Distribution Characteristics and Drug Resistance Changes of Clinical Isolates of
Acinetobacter Baumannii from 2016 to 2018[J].Medical Information,2019,32(20):119.[doi:10.3969/j.issn.1006-1959.2019.16.038]
[4]李 冲,赵 云,王 昊,等.ICU鲍曼不动杆菌血流感染临床特征及预后危险因素分析[J].医学信息,2020,33(13):54.[doi:10.3969/j.issn.1006-1959.2020.13.015]
LI Chong,ZHAO Yun,WANG Hao,et al.Clinical Characteristics and Prognostic Risk Factors of Bloodstream Infection of Acinetobacter Baumannii in ICU[J].Medical Information,2020,33(20):54.[doi:10.3969/j.issn.1006-1959.2020.13.015]
[5]李 南,曾凡业,仝梦婷,等.应用流式细胞术检测胃癌移植瘤小鼠脾脏中MDSC及T淋巴细胞亚群的变化[J].医学信息,2021,34(16):77.[doi:10.3969/j.issn.1006-1959.2021.16.021]
LI Nan,ZENG Fan-ye,TONG Meng-ting,et al.Application of Flow Cytometry to Detect the Changes of MDSC and T Lymphocyte Subsets in the Spleen of Mice with Gastric Cancer Transplantation[J].Medical Information,2021,34(20):77.[doi:10.3969/j.issn.1006-1959.2021.16.021]
[6]陈金莲,刘泉波.鲍曼不动杆菌耐药机制及治疗现状的研究[J].医学信息,2022,35(03):45.[doi:10.3969/j.issn.1006-1959.2022.03.011]
CHEN Jin-lian,LIU Quan-bo.Study on Drug Resistance Mechanism and Treatment Status of Acinetobacter Baumannii[J].Medical Information,2022,35(20):45.[doi:10.3969/j.issn.1006-1959.2022.03.011]
[7]赵津秀.反复呼吸道感染儿童检测C反应蛋白、T淋巴细胞亚群及免疫球蛋白在支原体肺炎诊断中的价值[J].医学信息,2022,35(04):174.[doi:10.3969/j.issn.1006-1959.2022.04.047]
ZHAO Jin-xiu.Diagnostic Value of C Reactive Protein, T Lymphocyte Subsets and Immunoglobulinin Children with Recurrent Respiratory Tract Infection[J].Medical Information,2022,35(20):174.[doi:10.3969/j.issn.1006-1959.2022.04.047]
[8]董惠霞,王 茜.非小细胞肺癌患者外周血T淋巴细胞亚群表达及其临床意义[J].医学信息,2023,36(18):136.[doi:10.3969/j.issn.1006-1959.2023.18.026]
DONG Hui-xia,WANG Qian.Expression and Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Patients with Non-small Cell Lung Cancer[J].Medical Information,2023,36(20):136.[doi:10.3969/j.issn.1006-1959.2023.18.026]